AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Lung cancer is the deadliest malignancy in the United States. Non-small cell lung cancer (NSCLC) accounts for 85% of cases and is frequently driven by activating mutations in the gene encoding the KRAS GTPase (e.g., KRASG12D). Our previous work demonstrated that Argonaute 2 (AGO2)-a component of the RNA-induced silencing complex (RISC)-physically interacts with RAS and promotes its downstream signaling. We therefore hypothesized that AGO2 could promote KRASG12D-dependent NSCLC in vivo. To test the hypothesis, we evaluated the impact of Ago2 knockout in the KPC (LSL-Kras  ;p53  ;Cre) mouse model of NSCLC. In KPC mice, intratracheal delivery of adenoviral Cre drives lung-specific expression of a stop-floxed KRASG12D allele and biallelic ablation of p53 Simultaneous biallelic ablation of floxed Ago2 inhibited KPC lung nodule growth while reducing proliferative index and improving pathological grade. We next applied the KP  C model, in which the Clara cell-specific CCSP-driven Cre activates KRASG12D and ablates a single p53 allele. In these mice, Ago2 ablation also reduced tumor size and grade. In both models, Ago2 knockout inhibited ERK phosphorylation (pERK) in tumor cells, indicating impaired KRAS signaling. RNA sequencing (RNA-seq) of KPC nodules and nodule-derived organoids demonstrated impaired canonical KRAS signaling with Ago2 ablation. Strikingly, accumulation of pERK in KPC organoids depended on physical interaction of AGO2 and KRAS. Taken together, our data demonstrate a pathogenic role for AGO2 in KRAS-dependent NSCLC. Given the prevalence of this malignancy and current difficulties in therapeutically targeting KRAS signaling, our work may have future translational relevance.
['Tien|Jean Ching-Yi|JC|', 'Chugh|Seema|S|', 'Goodrum|Andrew E|AE|', 'Cheng|Yunhui|Y|', 'Mannan|Rahul|R|0000-0002-6642-0468', 'Zhang|Yuping|Y|', 'Wang|Lisha|L|', 'Dommeti|Vijaya L|VL|', 'Wang|Xiaoming|X|0000-0001-9697-5571', 'Xu|Alice|A|', 'Hon|Jennifer|J|', 'Kenum|Carson|C|', 'Su|Fengyun|F|', 'Wang|Rui|R|0000-0002-5356-9685', 'Cao|Xuhong|X|', 'Shankar|Sunita|S|0000-0001-8743-7480', 'Chinnaiyan|Arul M|AM|']
AGO2 KRAS nonsmall cell lung cancer